NCT05047536 2025-12-19KZR-261 in Subjects With Advanced Solid MalignanciesKezar Life Sciences, Inc.Phase 1 Terminated61 enrolled 25 charts
NCT02650986 2025-06-17Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1Roswell Park Cancer InstitutePhase 1/2 Active not recruiting15 enrolled 12 charts